Literature DB >> 11357178

Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

Y H Zhao1, J Le, M H Abraham, A Hersey, P J Eddershaw, C N Luscombe, D Butina, G Beck, B Sherborne, I Cooper, J A Platts, D Boutina.   

Abstract

The human intestinal absorption of 241 drugs was evaluated. Three main methods were used to determine the human intestinal absorption: bioavailability, percentage of urinary excretion of drug-related material following oral administration, and the ratio of cumulative urinary excretion of drug-related material following oral and intravenous administration. The general solvation equation developed by Abraham's group was used to model the human intestinal absorption data of 169 drugs we considered to have reliable data. The model contains five Abraham descriptors calculated by the ABSOLV program. The results show that Abraham descriptors can successfully predict human intestinal absorption if the human absorption data is carefully classified based on solubility and administration dose to humans. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357178     DOI: 10.1002/jps.1031

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  50 in total

1.  Rate-limited steps of human oral absorption and QSAR studies.

Authors:  Yuan H Zhao; Michael H Abraham; Joelle Le; Anne Hersey; Chris N Luscombe; Gordon Beck; Brad Sherborne; Ian Cooper
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates.

Authors:  David Moreno; Daniel Plano; Ylenia Baquedano; Antonio Jiménez-Ruiz; Juan Antonio Palop; Carmen Sanmartín
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

3.  In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection.

Authors:  Hanlan Liu; Chantel Sabus; Guy T Carter; Chao Du; Alex Avdeef; Mark Tischler
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

4.  Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio.

Authors:  Eleni Rinaki; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 5.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

6.  Exploring different strategies for imbalanced ADME data problem: case study on Caco-2 permeability modeling.

Authors:  Hai Pham-The; Gerardo Casañola-Martin; Teresa Garrigues; Marival Bermejo; Isabel González-Álvarez; Nam Nguyen-Hai; Miguel Ángel Cabrera-Pérez; Huong Le-Thi-Thu
Journal:  Mol Divers       Date:  2015-12-07       Impact factor: 2.943

7.  The prediction of human oral absorption for diffusion rate-limited drugs based on heuristic method and support vector machine.

Authors:  H X Liu; R J Hu; R S Zhang; X J Yao; M C Liu; Z D Hu; B T Fan
Journal:  J Comput Aided Mol Des       Date:  2005-01       Impact factor: 3.686

8.  A 'rule of unity' for human intestinal absorption.

Authors:  S H Yalkowsky; J L H Johnson; T Sanghvi; S G Machatha
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

Review 9.  Performance of Kier-Hall E-state descriptors in quantitative structure activity relationship (QSAR) studies of multifunctional molecules.

Authors:  Darko Butina
Journal:  Molecules       Date:  2004-12-31       Impact factor: 4.411

10.  Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.

Authors:  Koteswara R Valasani; Gang Hu; Michael O Chaney; Shirley S Yan
Journal:  Chem Biol Drug Des       Date:  2012-11-14       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.